Scientific Team

The Scientific Team at ATXA Therapeutics is dedicated to advancing the late-stage preclinical and clinical development of innovative small molecule drugs for treating Pulmonary Arterial Hypertension. Comprising Senior Scientist, Program Manager & Scientist, and Research Scientist, the team conducts rigorous research, designs and manages experimental protocols, and ensures seamless progression from preclinical trials to clinical applications.